Inventor · disambiguated record
Steve Deharo
Also filed as: DEHARO STEVE
8 granted patents·3 pending applications·14 citations·filing 2011–2017
80Inventor score
Top patents by PatentIndex Score
11 records- 0182US10260097B2Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agentHARKIN DENIS PAUL·Filed 2012·Granted Apr 16, 2019·7 cites·21 claims
- 0281US11091809B2Molecular diagnostic test for cancerALMAC DIAGNOSTICS LTD·Filed 2013·Granted Aug 17, 2021·2 cites·22 claims
- 0376US10280468B2Molecular diagnostic test for predicting response to anti-angiogenic drugs and prognosis of cancerALMAC DIAGNOSTICS LTD·Filed 2015·Granted May 7, 2019·4 cites·4 claims
- 0475US10214777B2Molecular diagnostic test for cancerALMAC DIAGNOSTICS LTD·Filed 2015·Granted Feb 26, 2019·1 cites·28 claims
- 0568US9677140B2Molecular diagnostic test for cancerALMAC DIAGNOSTICS LTD·Filed 2013·Granted Jun 13, 2017·0 cites·14 claims
- 0664US10378066B2Molecular diagnostic test for cancerALMAC DIAGNOSTICS LTD·Filed 2017·Granted Aug 13, 2019·0 cites·31 claims
- 0743US11254986B2Gene signature for immune therapies in cancerALMAC DIAGNOSTICS LTD·Filed 2016·Granted Feb 22, 2022·0 cites·17 claims
- 0843US9670547B2Molecular diagnostic test for cancerO'DONNELL JUDE·Filed 2011·Granted Jun 6, 2017·0 cites·19 claims
- 0941US2016222460A1Molecular diagnostic test for oesophageal cancerALMAC DIAGNOSTICS LTD·Filed 2014·Application pending·0 cites
- 1041US2016222459A1Molecular diagnostic test for lung cancerALMAC DIAGNOSTICS LTD·Filed 2014·Application pending·0 cites
- 1134US2017088902A1Expression profiling for cancers treated with anti-angiogenic therapyALMAC DIAGNOSTICS LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steve Deharo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →